Showing results (91-100 of 111) with videos related to
Sort By:
Pageof 12
The Journal of Pathology. Clinical Research|September 12, 2023
Accounting for intensity variation in image analysis of large-scale multiplexed clinical trial datasetsAnja L Frei, Anthony McGuigan, Ritik Rak Sinha, et al.The Lancet. Gastroenterology & Hepatology|July 26, 2018
Mutation burden and other molecular markers of prognosis in colorectal cancer treated with curative intent: results from the QUASAR 2 clinical trial and an Australian community-based seriesEnric Domingo, Carme Camps, Pamela J Kaisaki, et al.Human Molecular Genetics|August 6, 2004
Distinct patterns of KRAS mutations in colorectal carcinomas according to germline mismatch repair defects and hMLH1 methylation statusCarla Oliveira, Jantine L Westra, Diego Arango, et al.Nature Genetics|October 16, 2007
A genome-wide association study shows that common alleles of SMAD7 influence colorectal cancer riskPeter Broderick, Luis Carvajal-Carmona, Alan M Pittman, et al.Nature Genetics|December 18, 2007
Common genetic variants at the CRAC1 (HMPS) locus on chromosome 15q13.3 influence colorectal cancer riskEmma Jaeger, Emily Webb, Kimberley Howarth, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 9, 2026
Three Versus 6 Months of Adjuvant Oxaliplatin-Fluoropyrimidine Chemotherapy for Colorectal Cancer: Final Results of SCOT-An International, Randomized, Phase III, Noninferiority TrialTimothy Iveson, Mark P Saunders, Caroline Kelly, et al.Nature Ecology & Evolution|September 5, 2018
The evolutionary landscape of colorectal tumorigenesisWilliam Cross, Michal Kovac, Ville Mustonen, et al.Gut|September 27, 2023
Molecular portraits of patients with intrahepatic cholangiocarcinoma who diverge as rapid progressors or long survivors on chemotherapyColm J O'Rourke, Massimiliano Salati, Colin Rae, et al.The Lancet. Gastroenterology & Hepatology|April 14, 2017
Somatic POLE proofreading domain mutation, immune response, and prognosis in colorectal cancer: a retrospective, pooled biomarker studyEnric Domingo, Luke Freeman-Mills, Emily Rayner, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 8, 2020
In-depth Clinical and Biological Exploration of DNA Damage Immune Response as a Biomarker for Oxaliplatin Use in Colorectal CancerSudhir B Malla, David J Fisher, Enric Domingo, et al.Pageof 12